2253719-35-4

2253719-35-4 structure
2253719-35-4 structure
  • Name: SY-LB-57
  • Chemical Name: SY-LB-57
  • CAS Number: 2253719-35-4
  • Molecular Formula: C16H13N3O
  • Molecular Weight: 263.29
  • Catalog: Research Areas Cardiovascular Disease
  • Create Date: 2022-09-27 19:37:59
  • Modify Date: 2025-08-28 07:26:49
  • SY-LB-57 is a highly potent bone morphogenetic protein (BMP) receptor signaling agonist. SY-LB-57 can be used in studies of diseases such as fractures and pulmonary arterial hypertension[1].

Name SY-LB-57
Description SY-LB-57 is a highly potent bone morphogenetic protein (BMP) receptor signaling agonist. SY-LB-57 can be used in studies of diseases such as fractures and pulmonary arterial hypertension[1].
Related Catalog
In Vitro SY-LB-57 (0.01-1000 μM, 24 h) can significantly induce cell proliferation at concentrations below 10 µM with an IC50 value of 807.93 µM in C2C12 cells[1]. SY-LB-57 (0.01-10 μM, 15-30 min) increases the phosphorylation of Smad protein and promotes p-Smad nuclear translocation while activates the PI3K/Akt pathway and induces cytoplasmic localization of p-Akt[1]. SY-LB-57 (0.01-10 μM, 24 h) can induce cell cycle shift towards proliferation[1]. Cell Viability Assay[1] Cell Line: C2C12 cells Concentration: 0.01-1000 μM Incubation Time: 24 hours Result: Resulted in 85% reduction in the cell viability of C2C12 at 1 mM while increased cell viability by 280%, 290%, 200%, 150% and 50% at 0.01 µM, 0.1 µM, 1 µM, 10 µM and 100 µM, respectively. Western Blot Analysis[1] Cell Line: C2C12 cells Concentration: 0.01-10 μM Incubation Time: 15min or 30 min Result: Significantly increased phosphorylation of Smad protein, 50% to 257% higher compared to control after 30 min. Showed a significant increase in p-Akt expression levels, exceeding the control by 667-1081% after 15 min. Cell Cycle Analysis[1] Cell Line: C2C12 cells Concentration: 0.01-10 μM Incubation Time: 24 hours Result: Resulted in a significant decrease in the percentage of G0/G1 phase cells and a dramatic increase in S and G2/M phase cells.
References

[1]. Sheyda Najafi, et al. Discovery of a novel class of benzimidazoles as highly effective agonists of bone morphogenetic protein (BMP) receptor signaling. Sci Rep. 2022 Jul 15;12(1):12146.

Molecular Formula C16H13N3O
Molecular Weight 263.29
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.